TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 65 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,394,000 | -8.7% | 28,431 | -15.6% | 4.91% | +15.3% |
| Q3 2015 | $4,815,000 | -22.7% | 33,696 | -22.3% | 4.26% | +1.6% |
| Q2 2015 | $6,228,000 | -41.9% | 43,343 | -43.0% | 4.19% | +33.8% |
| Q1 2015 | $10,722,000 | -23.2% | 76,023 | -19.3% | 3.13% | -7.7% |
| Q4 2014 | $13,961,000 | -31.9% | 94,208 | -29.2% | 3.39% | -57.0% |
| Q3 2014 | $20,486,000 | +3.4% | 133,150 | -5.7% | 7.90% | +107.2% |
| Q2 2014 | $19,812,000 | +18.6% | 141,270 | -6.2% | 3.81% | +9.9% |
| Q1 2014 | $16,709,000 | +16.5% | 150,535 | +3.8% | 3.47% | +13.0% |
| Q4 2013 | $14,346,000 | +26.7% | 145,053 | -2.6% | 3.07% | +3.8% |
| Q3 2013 | $11,319,000 | +37.8% | 148,931 | +1.4% | 2.96% | +15.1% |
| Q2 2013 | $8,212,000 | +6.2% | 146,900 | +11.5% | 2.57% | -22.9% |
| Q1 2013 | $7,736,000 | +215.0% | 131,806 | +161.9% | 3.33% | +336.0% |
| Q4 2012 | $2,456,000 | +85.4% | 50,329 | +73.5% | 0.76% | +47.2% |
| Q3 2012 | $1,325,000 | – | 29,003 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |